LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.45 | 84.90 | 8507 | 8254 | 1.0305 | 1.0091 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.16 | 84.90 | 1470 | 8141 | 0.1806 | 0.5421 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.16 | 84.90 | 8868 | 8141 | 1.0892 | 1.0261 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.16 | 84.90 | 1716 | 8141 | 0.2108 | 0.5788 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.16 | 84.90 | 8788 | 8141 | 1.0793 | 1.0233 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 84.90 | 1323 | 7680 | 0.1723 | 0.5258 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 84.90 | 9089 | 7680 | 1.1834 | 1.0525 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 84.90 | 1607 | 7680 | 0.2092 | 0.5722 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 87.86 | 84.90 | 9021 | 7680 | 1.1746 | 1.0501 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.57 | 84.90 | 1379 | 7494 | 0.1840 | 0.5392 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.57 | 84.90 | 9391 | 7494 | 1.2530 | 1.0710 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.57 | 84.90 | 1538 | 7494 | 0.2052 | 0.5654 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 89.57 | 84.90 | 9355 | 7494 | 1.2482 | 1.0698 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.27 | 84.90 | 1357 | 7420 | 0.1829 | 0.5368 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.27 | 84.90 | 9640 | 7420 | 1.2992 | 1.0828 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.27 | 84.90 | 1611 | 7420 | 0.2171 | 0.5783 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 91.27 | 84.90 | 9612 | 7420 | 1.2954 | 1.0819 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.98 | 84.90 | 1403 | 7257 | 0.1933 | 0.5482 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.98 | 84.90 | 9931 | 7257 | 1.3684 | 1.1002 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.98 | 84.90 | 1600 | 7257 | 0.2205 | 0.5802 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 92.98 | 84.90 | 9981 | 7257 | 1.3752 | 1.1018 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 84.90 | 1204 | 7000 | 0.1720 | 0.5168 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 84.90 | 10256 | 7000 | 1.4651 | 1.1237 | MN20160318_Q02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 84.90 | 1611 | 7000 | 0.2301 | 0.5878 | MN20160318_Q02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 94.68 | 84.90 | 10296 | 7000 | 1.4708 | 1.1250 | MN20160318_Q02 | D18 |